The ibuprofen API market was valued at more than US$ 626.2 Million in 2022, and it is projected to grow at a CAGR of 3% to US$ 772.2 Million by 2029. in accordance with the results of a recent Future Market Insights (FMI) study. The continuous need for affordable non-steroidal anti-inflammatory drugs (NSAID) and the size and …
Continue reading “Ibuprofen API Market Targets US$ 772.2 Million by 2029-FMI Study”